Discover key insights from Venus Concept Inc.'s Q3 2025 earnings call: EBD growth, Venus NOVA launch, and strategic challenges.

Q3 2025 Earnings Call November 13, 2025 8:00 AM ESTCompany ParticipantsRajiv Kanishka De Silva - CEO & DirectorDomenic Penna ...

Venus NOVA is supported by the Venus Jumpstart Program, a 30-day roadmap providing advanced clinical education, marketing enablement, and strategic implementation. This ensures seamless integration ...

Despite a decline in total revenue, Venus Concept Inc (VERO) focuses on strategic product launches and financial restructuring to drive future growth.

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...

FANCY popping to the other side of the world in just a few hours? It might not be as farfetched as it sounds. Aerospace ...

(2500.HK) today announced that Cardiovalve has submitted the CE technical file for its transcatheter tricuspid valve ...

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...

NASA is facing increasingly sharp challenges as it pursues its goal of landing astronauts on the moon again before this ...

Celebrated astrologer Vikkramm Chandirramani shares an in-depth insight into Hrithik Roshan’s life and career and predicts what lies ahead.

Venus Medtech’s Cardiovalve subsidiary today announced the submission of its heart valve replacement system for CE Mark.

On November 18, 2025, ten companies, including Ashok Leyland and Asian Paints, turn ex-dividend. Investors must hold shares ...